/ Active, not recruitingPhase 1/2 A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
100 Clinical Results associated with NC Medial Research Inc
0 Patents (Medical) associated with NC Medial Research Inc
100 Deals associated with NC Medial Research Inc
100 Translational Medicine associated with NC Medial Research Inc